Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending September 12, 2003. The report serves as a notification of changes in directors' interests in the company's Ordinary Shares.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is limited to reporting specific share transactions and does not contain financial performance data.
Material Changes
The filing details two specific transactions involving the GlaxoSmithKline Employee Trust ("GSK Trust") and the SmithKline Beecham Employee Share Option Plan 1991:
- September 9, 2003: The GSK Trust transferred 3,182 Ordinary Shares to plan participants.
- September 11, 2003: The GSK Trust transferred 16,966 Ordinary Shares to plan participants.
Directors Dr J-P Garnier and Mr J D Coombe are noted as having an interest in the shares held by the GSK Trust in the same capacity as other employees.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items.
Key Facts for Investor Verification
- Verify the total number of shares transferred from the GSK Trust to the Employee Share Option Plan during the reporting period (20,148 shares total).
- Confirm the specific dates of the share transfers (September 9 and September 11, 2003).
- Note that this filing does not contain financial results; investors should refer to the company's Form 20-F or interim reports for financial data.